Skip to content
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact

Category: Press Release

Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market

Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card

Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Company

← older
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
Menu
  • Home
  • About
    • Overview
    • Team Background
    • Public Healthcare
  • Team
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Senior Advisors
  • Programs
    • Overview
    • Pipeline
    • Strategic Partners
    • Drug Candidates
      • CO-sTiRNA™
      • MRI-1867
      • Additional R&D Programs
    • Scientific Publications
  • Media
  • News and Events
    • Press Releases
    • News
    • Events
    • Presentations
  • Investors
    • Company Information
    • News and Events
    • Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Data
    • Research Coverage
  • Contact
  • Contact
Menu
  • Contact

About

  • Overview
  • Team Background
  • Public Healthcare
Menu
  • Overview
  • Team Background
  • Public Healthcare

Team

  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Senior Advisors
Menu
  • Leadership
  • Board of Directors
  • Scientific Advisory Board
  • Senior Advisors

Programs

  • Overview
  • Pipeline
  • Strategic Partners
  • Drug Candidates
  • CO-sTiRNA™
  • MRI-1867
  • Additional R&D Programs
  • Scientific Publications
Menu
  • Overview
  • Pipeline
  • Strategic Partners
  • Drug Candidates
  • CO-sTiRNA™
  • MRI-1867
  • Additional R&D Programs
  • Scientific Publications

Media

  • Media
Menu
  • Media

News and Events

  • Press Releases
  • News
  • Events
  • Presentations
Menu
  • Press Releases
  • News
  • Events
  • Presentations

Investors

  • Company Information
  • News and Events
  • Presentations
  • SEC Filings
  • Corporate Governance
  • Stock Data
  • Research Coverage
Menu
  • Company Information
  • News and Events
  • Presentations
  • SEC Filings
  • Corporate Governance
  • Stock Data
  • Research Coverage
  • Contact
Menu
  • Contact

© 2023 Scopus BioPharma. All rights reserved | Privacy Policy | Cookies Policy